1st Circ. Won't Rethink Nexium Pay-For-Delay Decision
The First Circuit on Tuesday turned down bids by Nexium buyers for a rehearing of its November decision declining to revive a pay-for-delay class action against AstraZeneca and Ranbaxy over the heartburn medication....To view the full article, register now.
Already a subscriber? Click here to view full article